Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Rondelli

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Acta Clinica Belgica|June 3, 2011
Delayed diagnosis of abdominal mass due to morbid obesityB K Shah, Y S Huang, T V Valdez, et al.
Leukemia|November 1, 1992
Biological markers and minimal residual disease in hairy cell leukemiaF Lauria, D Raspadori, D Benfenati, et al.
Bone Marrow Transplantation|March 16, 2010
The impact of novel influenza A (H1N1) after hematopoietic SCTP Patel, K Sweiss, S Shatavi, et al.
Bone Marrow Transplantation|May 17, 2016
Melphalan 200 mg/m<sup>2</sup> in patients with renal impairment is associated with increased short-term toxicity but improved response and longer treatment-free survivalK Sweiss, S Patel, K Culos, et al.
Bone Marrow Transplantation|October 6, 2015
Decreased pulmonary function in asymptomatic long-term survivors after allogeneic hematopoietic stem cell transplantA L Oh, P Patel, K Sweiss, et al.
Leukemia & Lymphoma|November 1, 1993
High complete remission rate in hairy cell leukemia treated with 2-chlorodeoxyadenosineF Lauria, D Benfenati, D Raspadori, et al.
Blood|March 1, 1997
Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia: a new treatment schedule effective and safer in preventing infectious complicationsF Lauria, M Bocchia, G Marotta, et al.
Haematologica|March 26, 1999
Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complicationsF Lauria, M Bocchia, G Marotta, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Continuous infusion of interleukin-2 in two relapsed high grade non-Hodgkin lymphoma patients: effectiveness and tolerabilityF Lauria, P L Zinzani, D Rondelli, et al.
Bone Marrow Transplantation|November 30, 2005
The use of blood conservation methods in addition to erythropoietin allows myeloablative allogeneic stem cell transplantation without the use of blood productsS Ciurea, R Beri, L Dobogai, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Acta Clinica Belgica|June 3, 2011
Delayed diagnosis of abdominal mass due to morbid obesityB K Shah, Y S Huang, T V Valdez, et al.
Leukemia|November 1, 1992
Biological markers and minimal residual disease in hairy cell leukemiaF Lauria, D Raspadori, D Benfenati, et al.
Bone Marrow Transplantation|March 16, 2010
The impact of novel influenza A (H1N1) after hematopoietic SCTP Patel, K Sweiss, S Shatavi, et al.
Bone Marrow Transplantation|May 17, 2016
Melphalan 200 mg/m<sup>2</sup> in patients with renal impairment is associated with increased short-term toxicity but improved response and longer treatment-free survivalK Sweiss, S Patel, K Culos, et al.
Bone Marrow Transplantation|October 6, 2015
Decreased pulmonary function in asymptomatic long-term survivors after allogeneic hematopoietic stem cell transplantA L Oh, P Patel, K Sweiss, et al.
Leukemia & Lymphoma|November 1, 1993
High complete remission rate in hairy cell leukemia treated with 2-chlorodeoxyadenosineF Lauria, D Benfenati, D Raspadori, et al.
Blood|March 1, 1997
Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia: a new treatment schedule effective and safer in preventing infectious complicationsF Lauria, M Bocchia, G Marotta, et al.
Haematologica|March 26, 1999
Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complicationsF Lauria, M Bocchia, G Marotta, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Continuous infusion of interleukin-2 in two relapsed high grade non-Hodgkin lymphoma patients: effectiveness and tolerabilityF Lauria, P L Zinzani, D Rondelli, et al.
Bone Marrow Transplantation|November 30, 2005
The use of blood conservation methods in addition to erythropoietin allows myeloablative allogeneic stem cell transplantation without the use of blood productsS Ciurea, R Beri, L Dobogai, et al.
Pageof 8